Blood
sugar of diabetes patients is not easy to control. In severe cases, it can
damage many parts of the body, including the nerves and blood vessels in the
feet. As a result, diabetic patients have an increased risk of foot disease. Diabetic
shoes, also called therapeutic shoes, is specifically designed for foot
diseases of diabetic patients, which comfortable materials and scientific workmanship
can effectively protect the feet of diabetic patients and promote healthy foot
circulation, thereby reducing the risk of skin breakage in diabetic patients
with foot diseases. Therefore, wearing appropriate diabetic shoes can greatly
improve the condition of diabetic patients, thereby restoring their overall
quality of life. In addition, medical diabetic shoes can also reduce the high
care costs associated with diabetic foot ulcers and amputations.
The
diabetic shoes industry mainly has two sales channels, online and offline. Online
sales are simply the act of selling through the Internet or telephone. Amazon
is one of the platforms for online sales, which provides a dedicated online
sales system for enterprises. Offline channels mainly include purchase
channels in some shoe stores, department stores, chain stores, and specialty
stores. In 2012, the online and offline sales channel market shares of the
American diabetes shoes industry were 30.91% and 69.09%, respectively. The
market shares in 2019 are 32.21% and 67.79%. Although offline channels still
account for most of the market so far, it can be seen that with the development
of science and technology, the e-commerce industry and express delivery
services have developed rapidly, so the proportion of online channels is
increasing, and there is a trend of further expansion in the future. By 2027,
offline channels are expected to reach US$186.995 million. It is expected that
specialty stores and pharmacies will remain the main channels for consumers to
buy diabetic shoes. Online channels are expected to reach US$964.29 million,
with a compound annual growth rate of 9.63% from 2020 to 2027.
According to different application groups, USA diabetic shoes market can be divided into men and women by end-use. Although there is not much difference between male users and female users, in general, due to the higher prevalence of male diabetes, there are more male users of diabetic shoes in the United States. In 2012 and 2019, the market shares of men and women users of diabetic shoes in the United States were 53.24% and 46.76%, and 53.38% and 46.62%, respectively. It is predicted that the proportion of man users will continue to increase in the future.
Analysis on the Market Situation of Diabetic Shoes Industry in the United States
After a period of development, the diabetic shoes industry is in a growth period with not high market concentration. There are so many enterprises in this industry that the top three companies, Dr. Comfort, Drew Shoe and Pilgrim Shoes, account for only 9.70% of the market share in 2019, with 7.80%, 1.28% and 0.62% respectively.
Get the Complete Sample, Please Click: https://www.globalmarketmonitor.com/reports/763033-diabetic-shoes-market-report.html
The high prevalence of diabetes has led to increased demand for diabetes treatment and diabetes shoes. In 2018, 34.2 million Americans had diabetes, or 10.5 percent of the population, according to the American Diabetes Association. Second, government initiatives to raise awareness of the causes of diabetes have boosted the overall market in the region.
During the epidemic, multiple factors such as aviation control, sanitation and epidemic prevention, and delay in delivery of manufacturers due to the epidemic have caused diabetic shoes manufacturers to reduce the number of orders and sales in the short term. Secondly, the epidemic has had a negative impact on human spending power, mainly as the decline in income has reduced consumer demand for diabetic shoes.
Diabetic shoes have a long history of development in the US market, so people have a high degree of awareness of the great benefits of these professional shoes. Secondly, the high usage rate of these shoes has also been supported by medical reimbursement or medical insurance policies, which has greatly promoted the development of the American diabetic shoe market. In addition, the high availability of new and innovative diabetic shoes and the prevalence of diabetes also provide impetus to the American diabetic shoes market. Geographically, the American diabetic shoe market has become one of the strongest and most profitable markets.
The Development Trend of United States Diabetic Shoes Industry
The United States diabetic shoes market has a total sales value of 738.18 M USD back in 2012, and increase to 1551.36 M USD in 2020. We made the prediction that the value of diabetic shoes markets can be 2834.24 M USD by 2027. The CAGR of diabetic shoes is 8.99% from 2020 to 2027.
In 2018,
the new type of insoles developed by Purdue University researchers created many
growth opportunities for the American diabetic shoe market. In addition, in the
future, with technological progress and innovation, the development of related
new technologies and the use of new materials will bring more development
opportunities to the diabetic shoe market.
According
to the report, in recent years, the aging population in the United States has
become increasingly serious. As the aging process intensifies, elderly
patients with diabetes will gradually increase, and the performance and
treatment of elderly diabetes will receive more and more attention. Therefore,
the increase in the prevalence of diabetes in the elderly will promote the
development of this market. Besides, a sound medical insurance system
provides stable power support for the development of diabetes shoes in the US
market.
Although
the excellent performance of diabetic shoes can help treat a variety of diabetic
complications, consumers lack understanding of the benefits of diabetic shoes
limits the development of the diabetic shoes market. In addition, diabetes
treatment shoes and insoles are expensive, unsightly in appearance, and
unsuitable for wearing in hot seasons and other factors limit the application
of patients. Therefore, for diabetic patients with different foot pathologies,
companies should develop and innovate to provide shoes of different textures so
as to occupy a broader market.
We provide more professional and intelligent market reports to complement your business decisions.
Chinese